Reuters logo
BRIEF-Tesaro Announces Availability Of Varubi (Rolapitant) IV For Delayed Nausea And Vomiting Associated With Cancer Chemotherapy In The United States
November 28, 2017 / 1:09 PM / 15 days ago

BRIEF-Tesaro Announces Availability Of Varubi (Rolapitant) IV For Delayed Nausea And Vomiting Associated With Cancer Chemotherapy In The United States

Nov 28 (Reuters) - Tesaro Inc:

* TESARO ANNOUNCES AVAILABILITY OF VARUBI® (ROLAPITANT) IV FOR DELAYED NAUSEA AND VOMITING ASSOCIATED WITH CANCER CHEMOTHERAPY IN THE UNITED STATES Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below